Document is current
Any future updates will be listed below
-
Authors
Rotolo, Martina
Piombino, Claudia
Venturelli, Marta
Tenedini, Elena
Toss, Angela
Barbieri, Elena
Gasparini, Elisa
Marchi, Isabella
Domati, Federica
Civallero, Monica
Marcheselli, Luigi
Razzaboni, Elisabetta
Tagliafico, Enrico
Dominici, Massimo
Cortesi, Laura
- License Information
-
More Information
Article History
Received: 9 February 2025
Accepted: 25 November 2025
First Online: 13 December 2025
Competing interests
: A.T. received consulting fees and grants from Lilly, Pfizer, Novartis, MSD, AstraZeneca, Gilead, Seagen, Daiichi Sankyo; travel grants from Gilead, Daiichi Sankyo, Menarini, AstraZeneca. L.C. received grants from AstraZeneca, MSD, Pfizer; consulting fees and honoraria from AstraZeneca, Gilead, MSD, Roche, Pfizer, Daiichi Sankyo, Novartis; travel grants from Gilead, Pfizer, Daiichi Sankyo; Advisory Board of AstraZeneca, MSD, Novartis. The remaining authors declare no competing interests.
